BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 19667039)

  • 1. Progression of cardiac dysfunction in patients with atherosclerotic renovascular disease.
    Wright JR; Shurrab AE; Cooper A; Kalra PR; Foley RN; Kalra PA
    QJM; 2009 Oct; 102(10):695-704. PubMed ID: 19667039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular morphology and function in patients with atherosclerotic renovascular disease.
    Wright JR; Shurrab AE; Cooper A; Kalra PR; Foley RN; Kalra PA
    J Am Soc Nephrol; 2005 Sep; 16(9):2746-53. PubMed ID: 16049071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in left ventricular structure and function following renal artery revascularization.
    Corriere MA; Hoyle JR; Craven TE; D'Agostino RB; Edwards MS; Moore PS; Hansen KJ
    Ann Vasc Surg; 2010 Jan; 24(1):80-4. PubMed ID: 19631505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
    Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
    Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of renal artery revascularization on left ventricular hypertrophy, diastolic function, blood pressure, and the one-year outcome.
    Rzeznik D; Przewlocki T; Kablak-Ziembicka A; Kozanecki A; Roslawiecka A; Lach J; Tracz W; Podolec P
    J Vasc Surg; 2011 Mar; 53(3):692-7. PubMed ID: 21129903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease.
    Wright JR; Shurrab AE; Cheung C; Waldek S; O'Donoghue DJ; Foley RN; Mamtora H; Kalra PA
    Am J Kidney Dis; 2002 Jun; 39(6):1153-61. PubMed ID: 12046025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of maintenance recombinant human erythropoietin therapy on ambulatory blood pressure recordings: conventional, Doppler, and tissue Doppler echocardiographic parameters.
    Kirkpantur A; Kahraman S; Yilmaz R; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
    Artif Organs; 2005 Dec; 29(12):965-72. PubMed ID: 16305652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease.
    Kalra PA; Chrysochou C; Green D; Cheung CM; Khavandi K; Sixt S; Rastan A; Zeller T
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):1-10. PubMed ID: 19937777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of left ventricular hypertrophy following stenting of renal artery stenosis.
    Zeller T; Rastan A; Schwarzwälder U; Müller C; Frank U; Bürgelin K; Sixt S; Schwarz T; Noory E; Neumann FJ
    J Endovasc Ther; 2007 Apr; 14(2):189-97. PubMed ID: 17488176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of revascularization of atherosclerotic renal artery stenosis on coronary flow reserve and peripheral endothelial function.
    Koivuviita N; Tertti R; Luotolahti M; Raitakari O; Vahlberg T; Nuutila P; Knuuti J; Metsärinne K
    Nephron Clin Pract; 2011; 118(3):c241-8. PubMed ID: 21196769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of left ventricular hypertrophy in patients with chronic kidney disease.
    Yilmaz BA; Mete T; Dincer I; Kutlay S; Sengül S; Keven K; Ertürk S
    Ren Fail; 2007; 29(3):303-7. PubMed ID: 17497444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular hypertrophy and endothelial dysfunction in chronic kidney disease.
    Poulikakos D; Ross L; Recio-Mayoral A; Cole D; Andoh J; Chitalia N; Sharma R; Carlos Kaski J; Banerjee D
    Eur Heart J Cardiovasc Imaging; 2014 Jan; 15(1):56-61. PubMed ID: 23811493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER).
    Scarpioni R; Michieletti E; Cristinelli L; Ugolotti U; Scolari F; Venturelli C; Cancarini G; Pecchini P; Malberti F; Maroldi R; Rozzi G; Olivetti L
    J Nephrol; 2005; 18(4):423-8. PubMed ID: 16245247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endovascular management of atherosclerotic renovascular disease: early results following primary intervention.
    Corriere MA; Pearce JD; Edwards MS; Stafford JM; Hansen KJ
    J Vasc Surg; 2008 Sep; 48(3):580-7; discussion 587-8. PubMed ID: 18727962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of left ventricular hypertrophy in chronic kidney disease: an echocardiographic evaluation.
    Sambi RS; Gaur AK; Hotchandani R; Aggarwal KK; Kaur S; Gupta M; Jain S; Krishna CK; Chopra HK; Anand V; Srivastava S; Gupta R; Parashar SK
    Indian Heart J; 2011; 63(3):259-68. PubMed ID: 22734347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular mass in hypertensive patients with mild-to-moderate reduction of renal function.
    Cerasola G; Nardi E; Mulè G; Palermo A; Cusimano P; Guarneri M; Arsena R; Giammarresi G; Carola Foraci A; Cottone S
    Nephrology (Carlton); 2010 Mar; 15(2):203-10. PubMed ID: 20470280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term blood pressure monitoring and echocardiographic findings in patients with end-stage renal disease: reverse epidemiology explained?
    Borsboom H; Smans L; Cramer MJ; Kelder JC; Kooistra MP; Vos PF; van Jaarsveld BC
    Neth J Med; 2005 Nov; 63(10):399-406. PubMed ID: 16301761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac function in renovascular hypertensive patients with and without renal dysfunction.
    Khangura KK; Eirin A; Kane GC; Misra S; Textor SC; Lerman A; Lerman LO
    Am J Hypertens; 2014 Mar; 27(3):445-53. PubMed ID: 24162729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure.
    Tucker B; Fabbian F; Giles M; Thuraisingham RC; Raine AE; Baker LR
    Nephrol Dial Transplant; 1997 Apr; 12(4):724-8. PubMed ID: 9141001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular function in patients with chronic kidney disease evaluated by colour tissue Doppler velocity imaging.
    Hayashi SY; Rohani M; Lindholm B; Brodin LA; Lind B; Barany P; Alvestrand A; Seeberger A
    Nephrol Dial Transplant; 2006 Jan; 21(1):125-32. PubMed ID: 16221719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.